WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008102248) AN IMPROVED MONOLITHIC DRUG DELIVERY SYSTEM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/102248    International Application No.:    PCT/IB2008/000396
Publication Date: 28.08.2008 International Filing Date: 22.02.2008
IPC:
A61K 9/20 (2006.01)
Applicants: UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG [ZA/ZA]; 1 Jan Smuts Avenue, Braamfontein, Johannesburg (ZA) (For All Designated States Except US).
SIBAMBO, Sibongile, Ruth [ZA/ZA]; (ZA) (For US Only).
PILLAY, Vinees [ZA/ZA]; (ZA) (For US Only).
CHOONARA, Yahya, Essop [ZA/ZA]; (ZA) (For US Only)
Inventors: SIBAMBO, Sibongile, Ruth; (ZA).
PILLAY, Vinees; (ZA).
CHOONARA, Yahya, Essop; (ZA)
Agent: BOWMAN GILFILLAN INC. (JOHN & KERNICK); 165 West Street, Sandton, Johannesburg (ZA)
Priority Data:
2006/09747 23.02.2007 ZA
Title (EN) AN IMPROVED MONOLITHIC DRUG DELIVERY SYSTEM
(FR) DISPOSITIF DE DÉLIVRANCE DE MÉDICAMENTS MONOLITHIQUE AMÉLIORÉ
Abstract: front page image
(EN)This invention relates to an improved monolithic drug delivery dosage form which releases a pharmaceutically active agent at a predetermined rate. The dosage form comprises a salted-out or crosslinked polymer and a pharmaceutically active agent. The salted-out or crosslinked polymer functions to polymerically entangle the pharmaceutically active agent but, progressively relax on contact with an aqueous medium in use to release the pharmaceutically active agent at a predetermined rate.
(FR)La présente invention concerne une forme posologique de délivrance de médicaments monolithique améliorée qui libère un agent pharmaceutiquement actif à une vitesse prédéterminée. La forme posologique comprend un polymère relargué ou réticulé et un agent pharmaceutiquement actif. Le polymère relargué ou réticulé fonctionne pour permettre l'enchevêtrement polymère de l'agent pharmaceutiquement actif et sa libération progressive au contact d'un milieu aqueux durant l'utilisation pour libérer l'agent pharmaceutiquement actif à une vitesse prédéterminée.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)